We are enrolling participants 18 and older in a clinical study for Multiple Myeloma. To qualify, you must:
• Have been diagnosed with Multiple Myeloma
• Have received at least 1 prior line of anti-myeloma therapy
• Have documented evidence of progressive disease on or after the last regimen
Participants may receive compensation and study treatment.
Please contact us for more information.